İrkeç, C. Et Al. 2022. Decreased levels of soluble fractalkine as an earlybiomarker distinguishing secondary progressive from relapsing remitting multiple sclerosis. 4th International Turkic World Congress of Multiple Sclerosis , (Samarqand, Uzbekistan), 18-19.

İrkeç, C., Kuz, T., & Fidan, I., (2022). Decreased levels of soluble fractalkine as an earlybiomarker distinguishing secondary progressive from relapsing remitting multiple sclerosis . 4th International Turkic World Congress of Multiple Sclerosis (pp.18-19). Samarqand, Uzbekistan

İrkeç, CEYLA, Tuba Kuz, And Isıl Fidan. "Decreased levels of soluble fractalkine as an earlybiomarker distinguishing secondary progressive from relapsing remitting multiple sclerosis," 4th International Turkic World Congress of Multiple Sclerosis, Samarqand, Uzbekistan, 2022

İrkeç, CEYLA Et Al. "Decreased levels of soluble fractalkine as an earlybiomarker distinguishing secondary progressive from relapsing remitting multiple sclerosis." 4th International Turkic World Congress of Multiple Sclerosis , Samarqand, Uzbekistan, pp.18-19, 2022

İrkeç, C. Kuz, T. And Fidan, I. (2022) . "Decreased levels of soluble fractalkine as an earlybiomarker distinguishing secondary progressive from relapsing remitting multiple sclerosis." 4th International Turkic World Congress of Multiple Sclerosis , Samarqand, Uzbekistan, pp.18-19.

@conferencepaper{conferencepaper, author={CEYLA İRKEÇ Et Al. }, title={Decreased levels of soluble fractalkine as an earlybiomarker distinguishing secondary progressive from relapsing remitting multiple sclerosis}, congress name={4th International Turkic World Congress of Multiple Sclerosis}, city={Samarqand}, country={Uzbekistan}, year={2022}, pages={18-19} }